News | August 07, 2024
Bayer Group posts 2Q 2024 sales up 3.1% at € 11.14 billion
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency and severity of moderate to severe vasomotor symptoms over 12 weeks compared to placebo
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Abhay Soi, who had paid an income tax of approximately Rs 400 crore in the assessment year 2023-24 has been recognised as the “Top Individual tax payers having gross tax payable > Rs 10 Lakhs"
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
The pooled prevalence of GERD in the Indian population is 15.6 %
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The Unit has been issued GMP Certification from ANVISA-Brazil
Subscribe To Our Newsletter & Stay Updated
